Condition: Aneurysm Thoracic · Dissection of Aorta, Thoracic · Trauma · Sponsor: W.L.Gore & Associates
The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.
This description comes directly from the study's public registry record.
Hideyuki Saigusa · 819039126169 · hsaigusa@wlgore.com
Always discuss trial participation with your own doctor first.
| The University of Osaka Hospital | Osaka, Suita, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07049913